http://www.fda.gov/cder/orange/appendix_a.txt ACTHAR GEL, CORTICOTROPIN H.R.-50, HYDROCHLOROTHIAZIDE HABITROL, NICOTINE (OTC) HALCION, TRIAZOLAM HALDOL SOLUTAB, HALOPERIDOL HALDOL, HALOPERIDOL HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE HALDRONE, PARAMETHASONE ACETATE HALFAN, HALOFANTRINE HYDROCHLORIDE HALOG, HALCINONIDE HALOG-E, HALCINONIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL INTENSOL,...
NMEs Approved in CY 2000 NMEs Approved in Calendar Year 2000 NDA Number Generic Name- Trade Name Dosage Form Applicant - --- Classification- Approval Date 20-989 Cevimeline HCl Evoxac Capsule Snowbrand 1S 01-11-2000 21-014 Oxcarbazepine Trileptal Tablet Novartis Pharms 1S 01-14-2000 20-987 Pantoprazole Sodium Protonix Tablet Wyeth Ayerst 1S 02-02-2000 21-107 Alosetron HC1 Lotronex Tablet Glaxo Wellcome 1P 02...
author: Susan Daugherty
FDA Drug Approvals List April 2000 - Drug Approvals for April 2000 Definitions and Notes Original New Drug Applications Original Application #: 021025 Approval Date: 21-APR-00 Trade Name: EXELON Chemical Type: 3 Therapeutic Potential: S Dosage Form: SOLUTION Applicant: NOVARTIS PHARMACEUTICALS CORP Active Ingredient(s): RIVASTIGMINE TARTRATE OTC/RX Status: RX Indication(s): For the treatment of mild to moderate...
EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003 FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - - EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003 (SE1 -SE7)* and EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003 (SE8)* - GENERIC NAME APPLICANT NDA NUMBER SUPP TYPE SUPP NUMBER RECEIPT DATE APPROVAL DATE PRIORITY REVIEW TOTAL APPROVAL TIME (MONTHS) INDICATION/DESCRIPTION FLUOXETINE...
21081_Lantus Injection Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Lantus (Insulin Glargine [rDNA Origin]) Injection Company:--Aventis Pharmaceuticals Inc
author: Paul Stauffer
PowerPoint Presentation 3 Novo Nordisk in diabetes – agenda • Introduction • • • Diabetes as a value driver • • Insulin in conventional therapy • • NovoMix® 30 • • Mimicking real life with intensive treatment • • Levemir™ • • Insulin delivery Liraglutide - The first and only once daily human GLP-1 derivative...
author: Nanna Poulsen
Diabetes Monitor: Insulin glargine The Diabetes Monitor: Lantus (insulin glargine) information. ...
Patent and Exclusivity Terms TREATMENT UP TO 6 MONTHS WAS SHOWN EFFICACIOUS D-55 ADDITION OF A HIGHER DOSE OF NUTROPIN FOR PUBERTAL PATIENTS (PUBERTAL DOSE LESS THAN OR EQUAL TO 0.7MG/KG/WEEK) D-56 ADDITION OF POSTPRANDIAL DOSING D-57 3-HOUR INFUSION OF TAXOL GIVEN EVERY THREE WEEKS AT A DOSE OF 175MG/M2 FOLLOWED BY CISPLATIN AT A DOSE OF 75MG/M2 FOR THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN CANCER D-58...
Medicinal Products with a Community Marketing authorisation - Status October 2002 List The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit Medicinal Products with a Community Marketing authorisation Status: October 2002 Product Brandname INN Part A/ B Company Name Origin Therapeutic Area ATC Indication Presentation Form Strengths Number ...
author: EMEA
subject: List
Diabetes Mellitus, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - SECTION 3 Medical Conditions CHAPTER 34 - Diabetes Mellitus TOPICS - Diabetes Mellitus - Diabetes Mellitus Diabetes mellitus is a disease in which blood sugar (glucose)...
Slide 1 Khin Swe Myint Drug therapy in Diabetes Dr K S Myint Specialist Registrar Diagnosis of Diabetes 7.8- 11.1 6.1 – 7 Impair >11.1 >11.1 + symptoms >7 Diabetes <7.8 <6 Normal OGTT(2h) Random Fasting Aims of management n To achieve near normal glycaemia - - Short term- to prevent symptoms of hyper & hypo Long term- to prevent complications n Good quality of life, near normal life...
author: Dr Nyi Nyi Pe and Dr. Khin Swe Myint
Preview of the American Diabetes Association - 64th Scientific Sessions - Thomson Scientific Insulin analogs Aventis Pharma AG's insulin glulisine (Apidra), a fast-acting insulin analog that has been approved by the FDA for the control of hyperglycemia, will feature heavily at this year's conference.Insulin Glargine.
Contents Vol. 63, No. 16, 2003 63, No
author: Adis International Limited
subject: Drugs
Model Answers This effect is slow to develop and also resolve when clopidogrel is stopped (~ 1 week) ° Used for the following indications: prevention of coronary stent occlusion; in unstable angina; in stroke prophylaxis, especially when aspirin is not tolerated ° Efficacy in unstable angina shown in CURE trial where it was used in addition to aspirin; it also demonstrated a 2- fold...
Model Answers page 1
duplicates:http://www-clinpharm.medschl.cam.ac.uk/CPU_Clinical%20_Teaching/Past_papers/CPT%20exam%20Dec%202002%20Model%20Answers.pdf
http://www.novonordisk.com/images/investors/conferences_abstracts/abstracts_ada_2003.pdf agonist) 8 GLP- 1 derivative Liraglutide (NN2211) 11 Insulins Insulin aspart (NovoRapid ® /NovoLog ® )17 Biphasic insulin aspart (NovoMix ® 30/ NovoLog ® Mix 70/ 30) 23 Insulin detemir 26 Inhaled insulin (AERx ® iDMS) 33 Insulin delivery systems InDuo ® 38 InnoLet ® 43 Basic research 45 Diabetes healthcare...
Contents Vol. 61, No., 11, 2001 Contents Current Opinion Should Inhaled Corticosteroids be Used in the Long Term Treatment of Chronic Obstructive Pulmonary Disease
author: Adis International Limited
subject: Drugs
